La inmunosupresión es un factor mayor de riesgo en la recidiva de las lesiones del tracto genital inferior asociadas al virus del papiloma humano

Coronado Martín, Pluvio J; Fasero Laiz, MAría; Ramírez Mena, Mar; Arab Eblen, Clemente; Bellón del Amo, Mónica; García Santos, Javier; Vidart Aragón, José Antonio.
Prog. obstet. ginecol. (Ed. impr.) ; 53(5): 179-188, mayo 2010. tab, ilus
Artículo en Español | IBECS (España) | ID: ibc-79757

Documentos relacionados

  1. Role of Human Papillomavirus in Vulvar Cancer.
  2. A Systematic Review of Risk Factors for Development, Recurrence, and Progression of Vulvar Intraepithelial Neoplasia.
  3. Prevaccine Human Papillomavirus Status in Invasive and Intraepithelial Lesions of the Vulva in New Zealand Women.
  4. A meta-analysis of human papillomavirus prevalence and types among Iranian women with normal cervical cytology, premalignant lesions, and cervical cancer.
  5. Analysis of influencing factors of viral load in patients with high-risk human papillomavirus.
  6. Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer.
  7. Time trends in human papillomavirus prevalence and genotype distribution in vulvar carcinoma in Norway.
  8. Time trends in prevalence of p16 positivity and combined HPV/p16 positivity in a large cohort of Danish vulvar cancer patients.
  9. Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.
  10. Immunity to commensal papillomaviruses protects against skin cancer.